藥物成份

共有 21645 個藥物成份

AxSYM Rubella IgM reagent Pack 1. 1 Bottle (8.8mL) partially purified Rubella Virus coated Microparticles in Tris buffer with protein stabilizers.

• 關聯藥證數量: 1

AxSYM Salicylate Reagent Pack？1 Bottle (4.8mL) <0.01% Salicylate Fluorescein Tracer.？1 Bottle (3.5mL) <25% Salicylate Antiserum (Sheep and Rabbit).？1 Bottle (4.4mL) Pretreatment Solution.6 Bottles (2.5mL each) of XSYSTEMS Salicylate Calibrators, 0, 50, 100, 200, 400, 800 mg/L.3 Bottles (2.5mL each) of XSYSTEMS Salicylate Controls, 75, 300 and 600 mg/L.

• 關聯藥證數量: 1

AxSYM Theophylline II Reagent Pack1 Bottle (14.5mL)<0.05% Theophylline II Antiserum (Mouse, Monoclonal).1 Bottle (8.6mL) Pretreatment Solution1 Bottle (15.1mL)<0.01% Theophylline II Fluorescein Tracer in TRIS buffer.6 Bottle (5mL A, 4mL each B-F) of AxSYM Theophylline II Standard Calibrators Tehophylline Concentratin, A: 0; B:2.5; C:5.0; D:10.0; E:20.0; F:40.0 mg/LAxSYM Theophylline II Controls3 Bottles (8mL each) of AxSYM Theophylline II Controls L 7.0 mg/L M 12.0 mg/L H 26.0 mg/L

• 關聯藥證數量: 1

AxSYM Tobramycin Standard Calibrators (concentration:1.0, 4.0, 8.0 mg/L)

• 關聯藥證數量: 1

AxSYM Tobramycin Standard Calibrators (concentration:0, 0.5, 1.5, 3.0, 6.0, 10.0 mg/L)

• 關聯藥證數量: 1

AxSYM Total T3 Reagent Pack 1 Bottle(13.9 ml)T3：Alkaline Phosphatase Conjugate in Tromethamine HCl buffer with protein (bovine) stabilizers. 1 Bottle(6.4 ml)Anti-T3 (Sheep,Monoclonal)Coated Microparticles in TRIS buffer with protein (bovine) stabilizers. 1 Bottle (26.5 ml)TRIS Buffer.Preservatives：Sodium Azide and Antimicrobial Agents. AxSYM Total T3 Standard Calibrators 6 Bottles (4 mL each) of Total T3 Calibrators,A-F, concentration：0, 0.5, 1, 2, 4 and 8 ng/mL. AxSYM Total T3 Controls 3 Bottles(8 mL each) of Total T3 Controls,0.7, 1.5 and 3.7 ng/mL

• 關聯藥證數量: 1

AxSYM Total T4 Controls (concentration: 4.5, 8.0, 15.0 μg/dL)

• 關聯藥證數量: 1

AxSYM Total T4 Reagent Pack: 1 Bottle (4.8mL) T4 Pretreatment Solution. Surfactant in TRIS buffer 1 Bottle (3.5mL) T4 Antiserum (Mouse, Monoclonal) in phosphate buffer with protein stabilizers 1 Bottle (10mL) T4 Fluorescein Tracer in TRIS buffer containing surfactant.

• 關聯藥證數量: 1

AxSYM Total T4 Standard Calibrators (concentration: 0, 3.0, 6.0, 12.0, 18.0, 24.0 μg/dL)

• 關聯藥證數量: 1

AxSYM Toxo IgG Reagent Pack\n1 Bottle (7.8 mL). \n1 Bottle (9.6 mL).\n1 Bottle (25.8 mL). \Toxo IgG Calibrators \n1 Bottle (3 mL) of Toxo IgG Calibraotr (A).\n5 Bottle (3 mL each) of Toxo IgG Calibrators (B-F). \nToxo IgG Controls \n1 Bottle (5 mL) Toxo IgG Negative Control. \n1 Bottle (5 mL) Toxo IgG Positive Control.

• 關聯藥證數量: 1

AxSYM Toxo IgM Controls : \n AxSYM Toxo IgM Negative Control prepared with recalcified human plasma nonreactive for HBsAg, HIV-1 Ag or HIV-1 NAT, anti-HCV, anti-HIV-1/HIV-2 and T. gondii IgM Ab.\n AxSYM Toxo IgM positive Control prepared with recalcified human plasma reactive for T. gondii IgM Ab and nonreactive for HBsAg , HIV-1 Ag or HIV-1 NAT, anti-HCV and anti-HIV-1/HIV-2.

• 關聯藥證數量: 1

AxSYM Toxo IgM Reagent Pack : \n T. gondii Coated Microparticles in Tris buffer. \n Anti-Human IgM (goat) : Alkaline Phosphatase Conjugate in Tris buffer. \n Assay Diluent in Tris buffer. \n RF Neutralization Buffer, Citrate.\n\nAxSYM Toxo IgM Index Calibrator : \n AxSYM Toxo IgM Index Calibrator prepared with recalcified human plasma reactive for T. gondii IgM Ab and nnreactive for HBsAg, HIV-1 Ag or HIV-1 NAT, anti-HCV and anti-HIV-1/HIV-2.

• 關聯藥證數量: 1

AxSYM Troponin-I ADV Reagent Pack1 Bottle (13.1mL) Conjugate 2, Anti-biotin (mouse monoclonal): alkaline phosphatase (E.coli) conjugate.1 Bottle (4.9mL) Microparticles, Anti-troponin-I (mouse monoclonal) coated microparticles.1 Bottle (13.7mL) Conjugate 1, Anti-troponin-I (mouse monoclonal):biotin conjugate in TRIS buffer with protein (mouse and bovine) stabilizers.1 Bottle (17.0mL) Pre-INCUBATION Diluent, Diluent containing protein (mouse, goat, bovine, and E. coli lysate). 6 Bottles (4mL each) of AxSYM Troponin-I ADV Standard Calibrators (Conc.0-22.78 ng/mL)3 Bottles (8mL each) of AxSYM Troponin-I ADV Controls (Conc. 0.28-9.49 ng/mL)

• 關聯藥證數量: 1

Azacitidine Assay: 98.0%~102.0% on the anhydrous and solvent-free basis.

• 關聯藥證數量: 1

Azacitidine contains not less than 98.0 percent and not more than 102.0 percent of C8H12N4O5 calculated on the anhydrous and solvent-free basis.

• 關聯藥證數量: 1

Azathioprine (Process 2) contains not less than 98.5% and not more than 101.0% of C9H7N7O2S, calculated on anhydrous basis.

• 關聯藥證數量: 1

Azathioprine contains not less than 98.0% and not more than 101.5% of C9H7N7O2S calculated on the dried basis.

• 關聯藥證數量: 1

Azelaic acid contains not less 99.2% of C9H16O4

• 關聯藥證數量: 1

Azilsartan Kamedoxomil contains not less than 97.0% and not more than 102.0% of C30H23KN4O8, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Azithromycin contains 945 ug/mg~1030 ug/mg of C38H72N2O12, calculated on dried basis.

• 關聯藥證數量: 1

Azithromycin (Dihydrate) Content： 96.0%~102.0% on the anhydrous basis

• 關聯藥證數量: 1

Azithromycin 0.016-256 μg/mL。處方變更為：空白(核定事項另載於中文仿單)。

• 關聯藥證數量: 1

Azithromycin Dihydrate 94.5% - 103.0% of C38H72N2O12, calculated on anhydrous basis.

• 關聯藥證數量: 1

Azithromycin contains 2 molecules of water of hydration. It contains the equivalent of not less than 945 μg/mg and not more than 1030 μg/mg of azithromycin (C38H72N2O12), calculated on the anhydrous basis.

• 關聯藥證數量: 1

Azithromycin contains 96.0%~102.0% of C38H72N2O12, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Azithromycin contains not less than 945μg/mg And not more than 1030μg/mg of C38H72N2O12, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Azithromycin contains not less than 96.0% and not more than 102.0% of C38H72N2O12‧2H2O calculated on the anhydrous substance.

• 關聯藥證數量: 1

Azithromycin contains not less than 96.0% and not more than 102.0% of C38H72N2O12‧xH2O calculated on the anhydrous substance.

• 關聯藥證數量: 1

Azithromycin contains not less than 96.0% and not more than102.0% of C38H72N2O12‧xH2O calculated on the anhydrous substance.

• 關聯藥證數量: 1

Aztreonam

• 關聯藥證數量: 1

Aztreonam：0.016-256 μg/mL。處方變更為：空白(核定事項另載於中文仿單)。

• 關聯藥證數量: 1

Azulene Water Soluble contains not less than 98.5% and not more than 101.5% of C15H17NaO3S.1/2H2O.

• 關聯藥證數量: 1

A：Buffer sol.(R-1)\nB：Substrate sol.(R-2)

• 關聯藥證數量: 1

A：Reconstituting Solution(Liquid)\nB：Sample Diluent(Liquid)\nC：Sensitized Particles(Lyophilized)\nD：Unsensitized Particles(Lyophilized)\nE：Positive Control(Lyophilized)

• 關聯藥證數量: 1

B. MULTICINCTUS ANTIVENIN

• 關聯藥證數量: 1

B. MULTICINCTUS ANTIVENIN BIVALENT

• 關聯藥證數量: 1

B.C.G. VACCINE

• 關聯藥證數量: 1

B.H.T

• 關聯藥證數量: 1

B.H.T.

• 關聯藥證數量: 1

B.R.A.H.M.S CEA KRYPTOR CAL：Each vial contains highly purified human CEA, human serum.

• 關聯藥證數量: 1

B.R.A.H.M.S FSHKRYPTOR CAL:Each vial contains human FSH, new born calf serum,.

• 關聯藥證數量: 1

B.R.A.H.M.S Ferritin KRYPTOR CAL: Each vial contains highly purified human ferritin, human serum.

• 關聯藥證數量: 1

B.R.A.H.M.S Ferritin KRYPTOR QC: Each vial contains purified human ferritin and human serum.

• 關聯藥證數量: 1

B/AUSTRIA/1359417/2021 - LIKE VIRUS (B/SINGAPORE/WUH4618/2021)

• 關聯藥證數量: 1

B/Austria/1359417/2021 (B/Victoria lineage)-like virus

• 關聯藥證數量: 1

B/Austria/1359417/2021 - like strain (B/Austria/1359417/2021, BVR-26)

• 關聯藥證數量: 1

B/Austria/1359417/2021 - like strain (B/Michigan/01/2021, wild type)

• 關聯藥證數量: 1

B/BEIJING/184/93-LIKE STRAIN

• 關聯藥證數量: 1

B/Brisbane/60/2008-like strain (B/Brisbane/60/2008, wild type)

• 關聯藥證數量: 1

B/Colorado/06/2017-like virus (B/Maryland/15/2016, Reassortant NYMC BX-69A)

• 關聯藥證數量: 1

B/Massachusetts/02/2012

• 關聯藥證數量: 1

B/Phuket/3073/2013 (B/Yamagata lineage)

• 關聯藥證數量: 1

B/STRAIN

• 關聯藥證數量: 1

B/Singapore/INFTT-16-0610/2016 (a B/Phuket/3073/2013-like virus)

• 關聯藥證數量: 1

B/Washington/02/2019 (B/Victoria lineage)

• 關聯藥證數量: 1

B/Washington/02/2019-like virus (B/Victoria/705/2018 (BVR-11))

• 關聯藥證數量: 1

B2M ANTIBODY (PROCESSED GOAT SERA) 5.0 ML B2M COREAGENT (A MIXTURE OF BOVINE AND HUMAN PROTEINS) 5.0 ML

• 關聯藥證數量: 1

B4-RD1: The concentration of nonantibody reagent is 0.2% BSA, 0.01 M potassium, 0.15 M NaCl, 0.1% NaN3.\nAntibody:\nClone:89B\nHybridoma:NS/1-Ag4-1xBALB/c\nImmunogen :Tumor cells from a patient with B cell CLL\nIg chain:IgG1\nSpecies: Mouse\nSource: Mouse Ascites or Conditioned media\nPurification: Ion Exchange or Affinity Chromatography\nFluorescence: Excites at 485-570nm/Emits at 577nm\nConjugation: RD1(Phycoerythrin)\nMolar Ratio: RD1/Protein:0.5-1.5

• 關聯藥證數量: 1

B:SERUM DILUENT (LIQUID)

• 關聯藥證數量: 1

BACAMPICILLIN (HCL)

• 關聯藥證數量: 1

BACILLUS MESENTERICUS

• 關聯藥證數量: 1

BACTERIAL LIPOLYTIC ENZYME

• 關聯藥證數量: 1

BALSALAZIDE DISODIUM DIHYDRATE

• 關聯藥證數量: 1

BALSALAZIDE DISODIUM DIHYDRATE contains 98.0~102.0% (as dried basis)

• 關聯藥證數量: 1

BAMETHAN

• 關聯藥證數量: 1

BAMIFYLLINE HCL

• 關聯藥證數量: 1

BASIC KIT COMPONENTS:\nIgE MICROPLATE coated with anti-IgE. Each well is coated with monoclonal anti-human IgE.\nHRP-STREPTAVIDIN CONJUGATE：Each vial contains 13 ml of Streptavidin-Peroxidase conjugate in a red colored buffer, pH 5.5 supplemented with 0.001% Proclin 300.\nINCUBATION BUFFER/CALIBRATOR A：Each vial contains 8 ml of TRIS buffer pH8.4, supplemented with 0.005% Proclin300. The incubation buffer of the Basic kit is used as Calibrator A (Conc. 0 KIU/L).\nSUBSTRATE HS：Each vial contains 13ml of a ready-to-use stabilized mixture of 3,3,5,5 tetramethylbenzidine and hydrogen peroxide\nSTOP SOLUTION：Each vial contains 13ml of 0.3M sulphuric acid.\nWASH BUFFER 10x：Each vial contains 100ml of a washing solution, concentrated 10x, with Amphoteric. B 2.5 μg/ml.

• 關聯藥證數量: 1

BASILIXIMAB

• 關聯藥證數量: 1

BAZEDOXIFENE ACETATE MICRONIZED

• 關聯藥證數量: 1

BCG concentrate:\nSuccinate buffer 75 mmol/l;\nBromocresol green 0.15 mmol/l;\nBrij 35;\nPreservative;\nStandard:\nHuman serum albumin 45 g/l (4.5 g/dl);\nTris Buffer 100 mmol/l

• 關聯藥證數量: 1

BCP dye, Acetate Buffer, Surfactant, Microbial inhibitor.

• 關聯藥證數量: 1

BCP, EHR, FB, FVB, JAMES, NIN, NIT1, NIT2, PY2, TDA, VP 1, VP 2, VPA, VP B, XYL, Zn, ZYMA, ZYMB。

• 關聯藥證數量: 1

BD GeneOhm StaphSR Assay\nSample buffer 48/200 tests: Tris-EDTA buffer 60 x 1/240 x 1 mL.\nLysis tube 48/200 tests: Glass beads 50/200 tubes.\nMaster mix (8 reactions each) 48/200 tests (8/34 tubes): < 0.0005% DNA polymerase complex, <0.001% Internal control-non-infectious DNA containing MRSA-primer binding sequences and a unique sequence for probe hybridization, <0.002% primers, <0.002% molecular beacon probes, <0.05% dATP, dCTP, dGTP, dTTP, Bovine serum albumin, Carbohydrate, MgCl2, <0.001% non-infectious Staphylococcus epidermidis genomic DNA (ATCC 14990).\nControl DNA 48/200 tests (8/34 tubes): Tris-EDTA buffer, Carbohydrate, <0.001% non-infectious genomic MRSA DNA (ATCC43300).\nDiluent 48/200 tests (8 x 700/34 x 700 μL): Tris-HCl buffer, MgCl2, (NH4)2SO4, KCl.

• 關聯藥證數量: 1

BD Procount CD34 reagent A (nucleic acid dye/CD34 PE/CD45 PerCP)BD Procount Control reagent B (nucleic acid dye/γ1 PE/CD45 PerCP)BD Trucount tubes (25 tubes/pouch)

• 關聯藥證數量: 1

BD 菲科思凱立博FACSCalibur？流式細胞儀一台兼具分析與分選功能的多色桌上型流式細胞分析系統，結合樣品自動上樣盤、和各式各樣的試劑，以及功能強大的分析軟體以供選擇。

• 關聯藥證數量: 1

BDIS CD19 (Leu-12) PE reagent is a monoclonal antibody provided in buffered saline with gelatin and 0.1% sodium azide and is available in 50 tests. It contains PE-labeled CD19 (Leu-12), clone 4G7.8 The CD19 antigen, 95 kDa, is expressed on virtually all human B lymphocytes, which recognize 2% to 19% of peripheral blood lymphocytes.9

• 關聯藥證數量: 1

BEADS SOLID PHASE\nANTI-hBNP 125I\nSTANDARDS 0\nSTANDARDS A to F\nCONTROLS L and H\nDILUENT\nWASHING SOLUTION

• 關聯藥證數量: 1

BECAPLERMIN

• 關聯藥證數量: 1

BECLAMIDE

• 關聯藥證數量: 1

BECLOMETHASONE

• 關聯藥證數量: 1

BEEF TALLOW

• 關聯藥證數量: 1

BELLADONNA LEAF EXTRACT

• 關聯藥證數量: 1

BEMEGRIDE

• 關聯藥證數量: 1

BENDAZAC

• 關聯藥證數量: 1

BENFLUOREX HCL

• 關聯藥證數量: 1

BENPROPERINE

• 關聯藥證數量: 1

BENPROPERINE EMBONATE

• 關聯藥證數量: 1

BENPROPERINE PHOSPHATE CONTAINS NOT LESS THAN 98.5% OF C21H27F3NO.H3PO4 CALCULATED ON THE DRIED BASIS.

• 關聯藥證數量: 1

BENSERAZIDE

• 關聯藥證數量: 1

BENZALBUTYRAMIDE BETA-

• 關聯藥證數量: 1

BENZARONE, contains not less than 99.0% and not more than 100.0% of C17H14O3.

• 關聯藥證數量: 1

BENZETHONIUM CHLORIDE MONOHYDRATE

• 關聯藥證數量: 1

BENZOATE PROPYL GLYCOL ESTER

• 關聯藥證數量: 1

BENZOCTAMINE

• 關聯藥證數量: 1

BENZOCTAMINE HCL

• 關聯藥證數量: 1

BENZODODECINIUM

• 關聯藥證數量: 1

BENZOQUINAZEPINE

• 關聯藥證數量: 1

BENZOTRIAZOLE

• 關聯藥證數量: 1

BENZOYL PEROXIDE CADET

• 關聯藥證數量: 1

BENZYL ACETATE

• 關聯藥證數量: 1